Digest Réseau Comment ça marche
Digest / Communiqué

Resilient H1 2026 performance: BU Pharma +12%

Compatibilité
Sauvegarder(0)
partager
Resilient H1 2026 performance: BU Pharma +12%
Documents joints (1)

20094_171394_2026_oneinfo.pdf

Télécharger le dossier de presse ->
Coordonnées

Communiqués connexes

07/05/2026
Finance
Épargne/Affaires personnelles
Fonds d'investissement
Industrie
The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A today approved the Group's Interim Financial Report as of 31 March 2026.
Source
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Émetteur
1INFO
0
05/08/2025
Finance
Épargne/Affaires personnelles
Fonds d'investissement
Industrie
Growing revenue Adjusted EBITDA was €21.6 million, +35%, and margins for 16.8%
Source
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Émetteur
1INFO
0
08/09/2026
Finance
Épargne/Affaires personnelles
Fonds d'investissement
Industrie
Primo semestre 2026 solido: BU Pharma +12%
Source
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Émetteur
1INFO
0